Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ
Zmień bibliotekę

Wyszukujesz frazę ""Valganciclovir"" wg kryterium: Temat


Tytuł :
Treating HIV-associated cytomegalovirus retinitis with oral valganciclovir and intra-ocular ganciclovir by primary HIV clinicians in southern Myanmar: a retrospective analysis of routinely collected data.
Autorzy :
Murray J; Médecins Sans Frontières, Yangon, Myanmar.
Hilbig A; Médecins Sans Frontières, Yangon, Myanmar. .
Soe TT; Médecins Sans Frontières, Yangon, Myanmar.
Ei WLSS; Médecins Sans Frontières, Yangon, Myanmar.
Soe KP; Médecins Sans Frontières, Yangon, Myanmar.
Ciglenecki I; Médecins Sans Frontières, Geneva, Switzerland.
Pokaż więcej
Źródło :
BMC infectious diseases [BMC Infect Dis] 2020 Nov 13; Vol. 20 (1), pp. 842. Date of Electronic Publication: 2020 Nov 13.
Typ publikacji :
Journal Article
MeSH Terms :
Cytomegalovirus*
AIDS-Related Opportunistic Infections/*epidemiology
Antiviral Agents/*therapeutic use
Cytomegalovirus Retinitis/*drug therapy
Cytomegalovirus Retinitis/*epidemiology
Ganciclovir/*therapeutic use
Valganciclovir/*therapeutic use
AIDS-Related Opportunistic Infections/virology ; Administration, Oral ; Adult ; Antiviral Agents/administration & dosage ; Antiviral Agents/adverse effects ; Cytomegalovirus Retinitis/virology ; Female ; Ganciclovir/administration & dosage ; Ganciclovir/adverse effects ; HIV ; Humans ; Injections, Intraocular ; Male ; Middle Aged ; Myanmar/epidemiology ; Primary Health Care ; Retrospective Studies ; Treatment Outcome ; Valganciclovir/administration & dosage ; Valganciclovir/adverse effects ; Visual Acuity/drug effects
Czasopismo naukowe
Tytuł :
Combination Treatment With Letermovir and Ganciclovir for Maintenance Therapy of Multidrug-resistant CMV Infection in a Liver Transplant Recipient.
Autorzy :
Kronig I; Service des Maladies Infectieuses, Hôpitaux Universitaires de Genève, Genève, Switzerland.
Elkrief L; Service des Gastroenterologie, Hôpitaux Universitaires de Genève, Genève, Switzerland.
Berney T; Service Chirurgie, Hôpitaux Universitaires de Genève, Genève, Switzerland.
Van Delden C; Service des Maladies Infectieuses, Hôpitaux Universitaires de Genève, Genève, Switzerland.
Neofytos D; Service des Maladies Infectieuses, Hôpitaux Universitaires de Genève, Genève, Switzerland.
Pokaż więcej
Źródło :
Transplantation [Transplantation] 2020 Aug; Vol. 104 (8), pp. e248-e249.
Typ publikacji :
Case Reports; Letter
MeSH Terms :
Acetates/*therapeutic use
Antiviral Agents/*therapeutic use
Cytomegalovirus Infections/*drug therapy
Liver Transplantation/*adverse effects
Quinazolines/*therapeutic use
Valganciclovir/*therapeutic use
Acetates/pharmacology ; Allografts/virology ; Antiviral Agents/pharmacology ; Cytomegalovirus/drug effects ; Cytomegalovirus/genetics ; Cytomegalovirus/isolation & purification ; Cytomegalovirus Infections/diagnosis ; Cytomegalovirus Infections/transmission ; Cytomegalovirus Infections/virology ; Drug Resistance, Multiple, Viral/genetics ; Drug Therapy, Combination/methods ; Humans ; Liver/virology ; Liver Transplantation/methods ; Maintenance Chemotherapy/methods ; Off-Label Use ; Postoperative Care/methods ; Quinazolines/pharmacology ; Treatment Outcome ; Valganciclovir/pharmacology
Raport
Tytuł :
Valganciclovir Dosing for Cytomegalovirus Prophylaxis in Solid-organ Transplant Recipients on Continuous Veno-venous Hemodialysis.
Autorzy :
Jarrell AS; The Johns Hopkins Hospital, Department of Pharmacy, Division of Critical Care and Surgery, Baltimore, Maryland, USA.
Crow JR; The Johns Hopkins Hospital, Department of Pharmacy, Division of Critical Care and Surgery, Baltimore, Maryland, USA.
Strout SE; The Johns Hopkins Hospital, Department of Pharmacy, Division of Critical Care and Surgery, Baltimore, Maryland, USA.
Kruer RM; Indiana University Health-Adult Academic Health Center, Department of Pharmacy, Indianapolis, Indiana, USA.
Toman LP; The Johns Hopkins Hospital, Department of Pharmacy, Division of Critical Care and Surgery, Baltimore, Maryland, USA.
Dioverti-Prono MV; Johns Hopkins University School of Medicine, Department of Medicine, Division of Infectious Diseases, Baltimore, Maryland, USA.
Lees L; The Johns Hopkins Hospital, Department of Pharmacy, Division of Critical Care and Surgery, Baltimore, Maryland, USA.
Avery RK; Johns Hopkins University School of Medicine, Department of Medicine, Division of Infectious Diseases, Baltimore, Maryland, USA.
Marzinke MA; Johns Hopkins University School of Medicine, Department of Pathology, Baltimore, Maryland, USA.; Johns Hopkins University School of Medicine, Department of Medicine, Division of Clinical Pharmacology, Baltimore, Maryland, USA.
Pokaż więcej
Źródło :
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2021 Jul 01; Vol. 73 (1), pp. 101-106.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Continuous Renal Replacement Therapy*
Cytomegalovirus Infections*/drug therapy
Cytomegalovirus Infections*/prevention & control
Organ Transplantation*
Adult ; Aged ; Antiviral Agents/therapeutic use ; Cytomegalovirus ; Ganciclovir/therapeutic use ; Humans ; Middle Aged ; Prospective Studies ; Transplant Recipients ; Valganciclovir/therapeutic use
Czasopismo naukowe
Tytuł :
Cytomegalovirus in renal transplant recipients from living donors with and without valganciclovir prophylaxis and with immunosuppression based on anti-thymocyte globulin or basiliximab.
Autorzy :
Andrade-Sierra J; Department of Physiology, University Health Sciences Center, University of Guadalajara, Guadalajara, Jalisco, Mexico; Department of Nephrology and Organ Transplant Unit, Specialties Hospital, National Western Medical Centre, Mexican Institute of Social Security, Guadalajara, Jalisco, Mexico. Electronic address: .
Heredia-Pimentel A; Department of Nephrology and Organ Transplant Unit, Specialties Hospital, National Western Medical Centre, Mexican Institute of Social Security, Guadalajara, Jalisco, Mexico.
Rojas-Campos E; Medical Research Unit in Renal Diseases, Specialties Hospital, National Western Medical Centre, Mexican Institute of Social Security, Guadalajara, Jalisco, Mexico.
Ramírez Flores D; Department of Nephrology and Organ Transplant Unit, Specialties Hospital, National Western Medical Centre, Mexican Institute of Social Security, Guadalajara, Jalisco, Mexico.
Cerrillos-Gutierrez JI; Department of Nephrology and Organ Transplant Unit, Specialties Hospital, National Western Medical Centre, Mexican Institute of Social Security, Guadalajara, Jalisco, Mexico.
Miranda-Díaz AG; Department of Physiology, University Health Sciences Center, University of Guadalajara, Guadalajara, Jalisco, Mexico.
Evangelista-Carrillo LA; Department of Nephrology and Organ Transplant Unit, Specialties Hospital, National Western Medical Centre, Mexican Institute of Social Security, Guadalajara, Jalisco, Mexico.
Martínez-Martínez P; Department of Nephrology and Organ Transplant Unit, Specialties Hospital, National Western Medical Centre, Mexican Institute of Social Security, Guadalajara, Jalisco, Mexico.
Jalomo-Martínez B; Department of Nephrology and Organ Transplant Unit, Specialties Hospital, National Western Medical Centre, Mexican Institute of Social Security, Guadalajara, Jalisco, Mexico.
Gonzalez-Espinoza E; Department of Nephrology and Organ Transplant Unit, Specialties Hospital, National Western Medical Centre, Mexican Institute of Social Security, Guadalajara, Jalisco, Mexico.
Gómez-Navarro B; Department of Nephrology and Organ Transplant Unit, Specialties Hospital, National Western Medical Centre, Mexican Institute of Social Security, Guadalajara, Jalisco, Mexico.
Medina-Pérez M; Department of Nephrology and Organ Transplant Unit, Specialties Hospital, National Western Medical Centre, Mexican Institute of Social Security, Guadalajara, Jalisco, Mexico.
Nieves-Hernández JJ; Department of Nephrology and Organ Transplant Unit, Specialties Hospital, National Western Medical Centre, Mexican Institute of Social Security, Guadalajara, Jalisco, Mexico.
Pokaż więcej
Źródło :
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases [Int J Infect Dis] 2021 Jun; Vol. 107, pp. 18-24. Date of Electronic Publication: 2021 Apr 14.
Typ publikacji :
Journal Article
MeSH Terms :
Antilymphocyte Serum/*therapeutic use
Basiliximab/*therapeutic use
Cytomegalovirus/*isolation & purification
Cytomegalovirus Infections/*epidemiology
Kidney Transplantation/*adverse effects
Valganciclovir/*therapeutic use
Adult ; Antiviral Agents/therapeutic use ; Female ; Ganciclovir/therapeutic use ; Humans ; Immunosuppression/methods ; Immunosuppressive Agents/therapeutic use ; Living Donors ; Male ; Middle Aged ; Multivariate Analysis ; Mycophenolic Acid/therapeutic use ; Retrospective Studies ; Risk Factors ; Tacrolimus/therapeutic use ; Transplant Recipients
Czasopismo naukowe
Tytuł :
Impact of the patient's body weight on the efficacy and adverse events of valganciclovir for cytomegalovirus reactivation after hematopoietic stem cell transplantation.
Autorzy :
Misaki Y; Division of Hematology, Saitama Medical Center, Jichi Medical University, Saitama-City, Japan.
Kimura SI; Division of Hematology, Saitama Medical Center, Jichi Medical University, Saitama-City, Japan.
Kawamura M; Division of Hematology, Saitama Medical Center, Jichi Medical University, Saitama-City, Japan.
Kawamura S; Division of Hematology, Saitama Medical Center, Jichi Medical University, Saitama-City, Japan.
Takeshita J; Division of Hematology, Saitama Medical Center, Jichi Medical University, Saitama-City, Japan.
Yoshino N; Division of Hematology, Saitama Medical Center, Jichi Medical University, Saitama-City, Japan.
Yoshimura K; Division of Hematology, Saitama Medical Center, Jichi Medical University, Saitama-City, Japan.
Gomyo A; Division of Hematology, Saitama Medical Center, Jichi Medical University, Saitama-City, Japan.
Matsumi S; Division of Hematology, Saitama Medical Center, Jichi Medical University, Saitama-City, Japan.
Akahoshi Y; Division of Hematology, Saitama Medical Center, Jichi Medical University, Saitama-City, Japan.
Tamaki M; Division of Hematology, Saitama Medical Center, Jichi Medical University, Saitama-City, Japan.
Kusuda M; Division of Hematology, Saitama Medical Center, Jichi Medical University, Saitama-City, Japan.
Kameda K; Division of Hematology, Saitama Medical Center, Jichi Medical University, Saitama-City, Japan.
Wada H; Division of Hematology, Saitama Medical Center, Jichi Medical University, Saitama-City, Japan.
Kawamura K; Division of Hematology, Saitama Medical Center, Jichi Medical University, Saitama-City, Japan.
Sato M; Division of Hematology, Saitama Medical Center, Jichi Medical University, Saitama-City, Japan.
Terasako-Saito K; Division of Hematology, Saitama Medical Center, Jichi Medical University, Saitama-City, Japan.
Tanihara A; Division of Hematology, Saitama Medical Center, Jichi Medical University, Saitama-City, Japan.
Nakasone H; Division of Hematology, Saitama Medical Center, Jichi Medical University, Saitama-City, Japan.
Kako S; Division of Hematology, Saitama Medical Center, Jichi Medical University, Saitama-City, Japan.
Kanda Y; Division of Hematology, Saitama Medical Center, Jichi Medical University, Saitama-City, Japan.
Pokaż więcej
Źródło :
Transplant infectious disease : an official journal of the Transplantation Society [Transpl Infect Dis] 2020 Jun; Vol. 22 (3), pp. e13270. Date of Electronic Publication: 2020 Mar 11.
Typ publikacji :
Journal Article
MeSH Terms :
Body Weight*
Antiviral Agents/*adverse effects
Cytomegalovirus Infections/*drug therapy
Hematopoietic Stem Cell Transplantation/*adverse effects
Latent Infection/*drug therapy
Valganciclovir/*adverse effects
Adolescent ; Adult ; Antiviral Agents/therapeutic use ; Cytomegalovirus Infections/prevention & control ; Female ; Ganciclovir/therapeutic use ; Humans ; Male ; Middle Aged ; Retrospective Studies ; Valganciclovir/therapeutic use ; Young Adult
Czasopismo naukowe
Tytuł :
The Yield of Targeted Examination for the Detection of Symptomatic Congenital Cytomegalovirus Infection.
Autorzy :
Masarweh K; Department of Pediatrics A, Emek Medical Center, Afula, Israel.
Felszer-Fisch C; Department of Pediatrics A, Emek Medical Center, Afula, Israel.
Shinwell E; Department of Neonatology, Ziv Medical Center, Safed, Israel.; Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.
Hasanein J; Department of Neonatology, Emek Medical Center, Afula, Israel.
Peniakov M; Department of Neonatology, Emek Medical Center, Afula, Israel.
Weiner SA; Department of Neonatology, Emek Medical Center, Afula, Israel.
Lurye-Marcu B; Department of Neonatology, Ziv Medical Center, Safed, Israel.
Miron D; Department of Pediatrics A, Emek Medical Center, Afula, Israel.; Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
Pokaż więcej
Źródło :
The Israel Medical Association journal : IMAJ [Isr Med Assoc J] 2021 May; Vol. 23 (5), pp. 318-322.
Typ publikacji :
Journal Article; Multicenter Study; Observational Study
MeSH Terms :
Polymerase Chain Reaction*
Cytomegalovirus Infections/*diagnosis
Hearing Loss, Sensorineural/*diagnosis
Neonatal Screening/*methods
Antiviral Agents/administration & dosage ; Cytomegalovirus Infections/congenital ; Cytomegalovirus Infections/drug therapy ; DNA, Viral/urine ; Female ; Hearing Loss, Sensorineural/virology ; Humans ; Incidence ; Infant, Newborn ; Israel ; Pregnancy ; Pregnancy Complications, Infectious/virology ; Prospective Studies ; Valganciclovir/administration & dosage
Czasopismo naukowe
Tytuł :
One Year of Preemptive Valganciclovir Administration in Children After Liver Transplantation.
Autorzy :
Ueno T; Pediatric Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, Japan. Electronic address: .
Kodama T; Pediatric Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Noguchi Y; Pediatric Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Deguchi K; Pediatric Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Nomura M; Pediatric Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Saka R; Pediatric Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Watanabe M; Pediatric Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Tazuke Y; Pediatric Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Bessho K; Pediatrics, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Okuyama H; Pediatric Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Pokaż więcej
Źródło :
Transplantation proceedings [Transplant Proc] 2020 Jul - Aug; Vol. 52 (6), pp. 1852-1854. Date of Electronic Publication: 2020 Jun 20.
Typ publikacji :
Clinical Trial; Journal Article
MeSH Terms :
Liver Transplantation*/adverse effects
Antiviral Agents/*administration & dosage
Cytomegalovirus Infections/*prevention & control
Valganciclovir/*administration & dosage
Adolescent ; Antiviral Agents/adverse effects ; Child ; Child, Preschool ; Cytomegalovirus Infections/epidemiology ; Cytomegalovirus Infections/immunology ; Female ; Ganciclovir/therapeutic use ; Humans ; Immunocompromised Host ; Incidence ; Living Donors ; Male ; Time Factors ; Valganciclovir/adverse effects
Czasopismo naukowe
Tytuł :
Efficacy, safety, and pharmacokinetics of oral valganciclovir in patients with congenital cytomegalovirus infection.
Autorzy :
Suganuma E; Division of Infectious Diseases and Immunology, Saitama Children's Medical Center, Saitama, Japan. Electronic address: .
Sakata H; Division of Otorhinolaryngology, Kawagoe Otology Institute, Saitama, Japan.
Adachi N; Division of Otolaryngology, Saitama Children's Medical Center, Saitama, Japan.
Asanuma S; Division of Otolaryngology, Saitama Children's Medical Center, Saitama, Japan.
Furuichi M; Division of Infectious Diseases and Immunology, Saitama Children's Medical Center, Saitama, Japan.
Uejima Y; Division of Infectious Diseases and Immunology, Saitama Children's Medical Center, Saitama, Japan.
Sato S; Division of Infectious Diseases and Immunology, Saitama Children's Medical Center, Saitama, Japan.
Abe T; Department of Pharmacy, Saitama Children's Medical Center, Saitama, Japan.
Matsumoto D; Department of Pharmacy, Saitama Children's Medical Center, Saitama, Japan.
Takahashi R; Department of Pharmacy, Saitama Children's Medical Center, Saitama, Japan.
Yamamoto S; Department of Pharmacy, Saitama Children's Medical Center, Saitama, Japan.
Kawano Y; Division of Infectious Diseases and Immunology, Saitama Children's Medical Center, Saitama, Japan.
Arai T; MicroSKY Lab, Inc., Tokyo, Japan.
Oh-Ishi T; Division of Infectious Diseases and Immunology, Saitama Children's Medical Center, Saitama, Japan; The Medical and Nursing Institution of Akitsu Ryoiku-En for Children/Adults with Severe Motor and Intellectual Disabilities, Tokyo, Japan.
Pokaż więcej
Źródło :
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy [J Infect Chemother] 2021 Feb; Vol. 27 (2), pp. 185-191. Date of Electronic Publication: 2020 Sep 06.
Typ publikacji :
Journal Article; Observational Study
MeSH Terms :
Cytomegalovirus Infections*/drug therapy
Hearing Loss, Sensorineural*/drug therapy
Antiviral Agents/adverse effects ; Child ; Child, Preschool ; Ganciclovir/adverse effects ; Humans ; Infant ; Infant, Newborn ; Japan ; Valganciclovir/adverse effects
Czasopismo naukowe
Tytuł :
Efficacy and safety of valganciclovir in patients with symptomatic congenital cytomegalovirus disease: Study Protocol Clinical Trial (SPIRIT Compliant).
Autorzy :
Morioka I; Department of Pediatrics and Child Health, Nihon University School of Medicine.
Kakei Y; Department of Oral and Maxillofacial Surgery.
Omori T; Division of Biostatistics, Department of Social/Community Medicine and Health Science.
Nozu K; Department of Pediatrics, Kobe University Graduate School of Medicine, Kobe.
Fujioka K; Department of Pediatrics, Kobe University Graduate School of Medicine, Kobe.
Yoshikawa T; Department of Pediatrics, Fujita Health University School of Medicine, Toyoake.
Moriuchi H; Department of Pediatrics, Nagasaki University Graduate School of Medicine, Nagasaki.
Ito Y; Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya.
Oka A; Department of Pediatrics, The University of Tokyo, Tokyo, Japan.
Pokaż więcej
Źródło :
Medicine [Medicine (Baltimore)] 2020 Apr; Vol. 99 (17), pp. e19765.
Typ publikacji :
Journal Article; Multicenter Study
MeSH Terms :
Clinical Protocols*
Cytomegalovirus Infections/*drug therapy
Valganciclovir/*standards
Administration, Oral ; Antiviral Agents/standards ; Antiviral Agents/therapeutic use ; Cytomegalovirus/drug effects ; Cytomegalovirus/pathogenicity ; Female ; Humans ; Infant ; Infant, Newborn ; Infectious Disease Transmission, Vertical ; Japan ; Male ; Prospective Studies ; Valganciclovir/therapeutic use
Czasopismo naukowe
Tytuł :
Virus-specific memory T cell responses unmasked by immune checkpoint blockade cause hepatitis.
Autorzy :
Hutchinson JA; Department of Surgery, University Hospital Regensburg, Regensburg, Germany. .
Kronenberg K; Department of Surgery, University Hospital Regensburg, Regensburg, Germany.
Riquelme P; Department of Surgery, University Hospital Regensburg, Regensburg, Germany.
Wenzel JJ; Institute of Clinical Microbiology and Hygiene, University Hospital Regensburg, Regensburg, Germany.
Glehr G; Institute of Functional Genomics and Statistical Bioinformatics, University of Regensburg, Regensburg, Germany.
Schilling HL; Department of Surgery, University Hospital Regensburg, Regensburg, Germany.
Zeman F; Center for Clinical Studies, University Hospital Regensburg, Regensburg, Germany.
Evert K; Institute of Pathology, University Hospital Regensburg, Regensburg, Germany.
Schmiedel M; Department of Nuclear Medicine, University Hospital Regensburg, Regensburg, Germany.
Mickler M; Department of Dermatology, University Hospital Regensburg, Regensburg, Germany.
Drexler K; Department of Dermatology, University Hospital Regensburg, Regensburg, Germany.
Bitterer F; Department of Surgery, University Hospital Regensburg, Regensburg, Germany.
Cordero L; Department of Surgery, University Hospital Regensburg, Regensburg, Germany.
Beyer L; Institute of Radiology, University Hospital Regensburg, Regensburg, Germany.
Bach C; Department of Medicine V, University Hospital Erlangen, Erlangen, Germany.
Koestler J; Institute of Clinical Microbiology and Hygiene, University Hospital Regensburg, Regensburg, Germany.
Burkhardt R; Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, Regensburg, Germany.
Schlitt HJ; Department of Surgery, University Hospital Regensburg, Regensburg, Germany.
Hellwig D; Department of Nuclear Medicine, University Hospital Regensburg, Regensburg, Germany.
Werner JM; Department of Surgery, University Hospital Regensburg, Regensburg, Germany.
Spang R; Institute of Functional Genomics and Statistical Bioinformatics, University of Regensburg, Regensburg, Germany.
Schmidt B; Institute of Clinical Microbiology and Hygiene, University Hospital Regensburg, Regensburg, Germany.
Geissler EK; Department of Surgery, University Hospital Regensburg, Regensburg, Germany.; Personalised Tumour Therapy, Fraunhofer Institute for Experimental Medicine and Toxicology, Regensburg, Germany.
Haferkamp S; Department of Dermatology, University Hospital Regensburg, Regensburg, Germany.
Pokaż więcej
Źródło :
Nature communications [Nat Commun] 2021 Mar 04; Vol. 12 (1), pp. 1439. Date of Electronic Publication: 2021 Mar 04.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
CD4-Positive T-Lymphocytes/*immunology
CTLA-4 Antigen/*antagonists & inhibitors
Cytomegalovirus Infections/*drug therapy
Hepatitis A/*prevention & control
Immune Checkpoint Inhibitors/*therapeutic use
Programmed Cell Death 1 Receptor/*antagonists & inhibitors
Antiviral Agents/therapeutic use ; CD4-Positive T-Lymphocytes/transplantation ; CD8-Positive T-Lymphocytes/immunology ; Cytomegalovirus/drug effects ; Cytomegalovirus/immunology ; Hepatitis A/immunology ; Hepatitis A/virology ; Humans ; Immunologic Memory/immunology ; Melanoma/drug therapy ; Valganciclovir/therapeutic use ; Viral Load
Czasopismo naukowe
Tytuł :
Cytomegalovirus endotheliitis with recurrent anterior uveitis and secondary glaucoma misdiagnosed as HLA-B27 uveitis.
Autorzy :
Tendolkar S; Cornea Service, LV Prasad Eye Institute, Hyderabad, Telangana, India.
Murthy SI; Cornea Service, LV Prasad Eye Institute, Hyderabad, Telangana, India .
Bhatia P; Department of Ophthalmology, Mediclinic Welcare Hospital, Dubai, UAE.
Senthil S; VST Center for Glaucoma, LV Prasad Eye Institute, Hyderabad, Telangana, India.
Pokaż więcej
Źródło :
BMJ case reports [BMJ Case Rep] 2021 Feb 19; Vol. 14 (2). Date of Electronic Publication: 2021 Feb 19.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Diagnostic Errors*
Cytomegalovirus Infections/*complications
Cytomegalovirus Infections/*diagnosis
Endothelium, Corneal/*virology
Glaucoma/*complications
Uveitis/*complications
Antiviral Agents/therapeutic use ; Cytomegalovirus/isolation & purification ; Cytomegalovirus Infections/drug therapy ; Endothelium, Corneal/drug effects ; Endothelium, Corneal/surgery ; HLA-B27 Antigen ; Humans ; Male ; Middle Aged ; Uveitis/diagnosis ; Uveitis/surgery ; Valganciclovir/therapeutic use
Czasopismo naukowe
Tytuł :
Population Pharmacokinetics of Intravenous Ganciclovir and Oral Valganciclovir in a Pediatric Population To Optimize Dosing Regimens.
Autorzy :
Nguyen T; EA7323, Evaluation des Thérapeutiques et Pharmacologie Périnatale et Pédiatrique, Université de Paris, Paris, France.
Oualha M; EA7323, Evaluation des Thérapeutiques et Pharmacologie Périnatale et Pédiatrique, Université de Paris, Paris, France.; Service de Réanimation et Surveillance Continue Médico-Chirurgicales Pédiatriques, Hôpital Necker Enfants Malades, Paris, France.
Briand C; Service d'Hématologie, Immunologie et Rhumatologie Pédiatrique, Hôpital Necker Enfants Malades, Paris, France.
Bendavid M; Service de Réanimation et Surveillance Continue Médico-Chirurgicales Pédiatriques, Hôpital Necker Enfants Malades, Paris, France.
Béranger A; EA7323, Evaluation des Thérapeutiques et Pharmacologie Périnatale et Pédiatrique, Université de Paris, Paris, France.; Service de Réanimation et Surveillance Continue Médico-Chirurgicales Pédiatriques, Hôpital Necker Enfants Malades, Paris, France.
Benaboud S; EA7323, Evaluation des Thérapeutiques et Pharmacologie Périnatale et Pédiatrique, Université de Paris, Paris, France.; Service de Pharmacologie Clinique, AP-HP, Hôpital Cochin, Paris, France.
Tréluyer JM; EA7323, Evaluation des Thérapeutiques et Pharmacologie Périnatale et Pédiatrique, Université de Paris, Paris, France.; Service de Pharmacologie Clinique, AP-HP, Hôpital Cochin, Paris, France.; Unité de Recherche Clinique Paris Descartes Necker Cochin, AP-HP, Paris, France.; CIC-1419 Inserm, Cochin-Necker, Paris, France.
Zheng Y; EA7323, Evaluation des Thérapeutiques et Pharmacologie Périnatale et Pédiatrique, Université de Paris, Paris, France.; Service de Pharmacologie Clinique, AP-HP, Hôpital Cochin, Paris, France.
Foissac F; EA7323, Evaluation des Thérapeutiques et Pharmacologie Périnatale et Pédiatrique, Université de Paris, Paris, France.; Unité de Recherche Clinique Paris Descartes Necker Cochin, AP-HP, Paris, France.; CIC-1419 Inserm, Cochin-Necker, Paris, France.
Winter S; Service d'Hématologie, Immunologie et Rhumatologie Pédiatrique, Hôpital Necker Enfants Malades, Paris, France.
Gana I; EA7323, Evaluation des Thérapeutiques et Pharmacologie Périnatale et Pédiatrique, Université de Paris, Paris, France.; Service de Pharmacologie Clinique, AP-HP, Hôpital Cochin, Paris, France.
Boujaafar S; EA7323, Evaluation des Thérapeutiques et Pharmacologie Périnatale et Pédiatrique, Université de Paris, Paris, France.; Service de Pharmacologie Clinique, AP-HP, Hôpital Cochin, Paris, France.
Lopez V; Service de Réanimation Cardiaque Pédiatrique, Hôpital Necker Enfants Malades, Paris, France.
Berthaud R; EA7323, Evaluation des Thérapeutiques et Pharmacologie Périnatale et Pédiatrique, Université de Paris, Paris, France.; CIC-1419 Inserm, Cochin-Necker, Paris, France.; Service de Néphrologie Pédiatrique, Hôpital Necker Enfants Malades, Paris, France.
Demir Z; Service de Gastro-Entérologie, Hépatologie et Nutrition Pédiatriques, Hôpital Necker Enfants Malades, Paris, France.
Bouazza N; EA7323, Evaluation des Thérapeutiques et Pharmacologie Périnatale et Pédiatrique, Université de Paris, Paris, France.; Unité de Recherche Clinique Paris Descartes Necker Cochin, AP-HP, Paris, France.; CIC-1419 Inserm, Cochin-Necker, Paris, France.
Hirt D; EA7323, Evaluation des Thérapeutiques et Pharmacologie Périnatale et Pédiatrique, Université de Paris, Paris, France .; Service de Pharmacologie Clinique, AP-HP, Hôpital Cochin, Paris, France.; INSERM, U1018, Hôpital de Bicêtre, Le Kremlin-Bicêtre, France.
Pokaż więcej
Źródło :
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2021 Feb 17; Vol. 65 (3). Date of Electronic Publication: 2021 Feb 17 (Print Publication: 2021).
Typ publikacji :
Journal Article
MeSH Terms :
Cytomegalovirus Infections*/drug therapy
Ganciclovir*/therapeutic use
Administration, Oral ; Antiviral Agents/therapeutic use ; Child ; Humans ; Valganciclovir/therapeutic use
Czasopismo naukowe
Tytuł :
Ganciclovir-resistant post-transplant cytomegalovirus infection due to combined deletion mutation at codons 595-596 of the UL97 gene.
Autorzy :
Leung PYM; Department of Nephrology, Austin Health, Melbourne, Vic., Australia.
Tran T; Virus Identification Laboratory, Victorian Infectious Diseases Reference Laboratory, The Peter Doherty Institute for Infection and Immunity, Melbourne, Vic., Australia.
Testro A; Liver Transplant Unit, Austin Health, Melbourne, Vic., Australia.
Paizis K; Department of Nephrology, Austin Health, Melbourne, Vic., Australia.
Kwong J; Department of Infectious Diseases, Austin Health, Melbourne, Vic., Australia.
Whitlam JB; Department of Nephrology, Austin Health, Melbourne, Vic., Australia.; Department of Medicine, University of Melbourne, Melbourne, Vic., Australia.
Pokaż więcej
Źródło :
Transplant infectious disease : an official journal of the Transplantation Society [Transpl Infect Dis] 2019 Dec; Vol. 21 (6), pp. e13168. Date of Electronic Publication: 2019 Sep 18.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Antiviral Agents/*pharmacology
Cytomegalovirus/*genetics
Drug Resistance, Viral/*genetics
Kidney Transplantation/*adverse effects
Liver Transplantation/*adverse effects
Phosphotransferases (Alcohol Group Acceptor)/*genetics
Valganciclovir/*pharmacology
Aged ; Antiviral Agents/therapeutic use ; Cytomegalovirus/immunology ; Foscarnet/pharmacology ; Foscarnet/therapeutic use ; Hepatorenal Syndrome/surgery ; Humans ; Kidney Transplantation/methods ; Liver Transplantation/methods ; Male ; Sequence Deletion ; Valganciclovir/therapeutic use ; Viral Load/drug effects ; Viral Proteins/genetics ; Virus Replication/drug effects
Czasopismo naukowe
Tytuł :
Maribavir for Preemptive Treatment of Cytomegalovirus Reactivation.
Autorzy :
Maertens J; From the Hematology Department, University Hospitals Leuven, KU Leuven, Leuven (J.M.), and the Section of Hematology, Cliniques Universitaires Saint-Luc, Brussels (X.P.) - both in Belgium; the Hematology Department, Henri Mondor Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP) and University Paris-Est-Créteil, Créteil (C.C.), and AP-HP Hôpital Paul Brousse, Villejuif (F.S.) - all in France; the Medical University of Vienna, General Hospital, Vienna (P.J.); Shire, Wayne, PA (M.U., S.V.); Shire, Lexington, MA (J.W., A.W.); and the Department of Infectious Diseases, University Hospital Essen, University Duisburg-Essen, Essen, Germany (O.W.).
Cordonnier C; From the Hematology Department, University Hospitals Leuven, KU Leuven, Leuven (J.M.), and the Section of Hematology, Cliniques Universitaires Saint-Luc, Brussels (X.P.) - both in Belgium; the Hematology Department, Henri Mondor Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP) and University Paris-Est-Créteil, Créteil (C.C.), and AP-HP Hôpital Paul Brousse, Villejuif (F.S.) - all in France; the Medical University of Vienna, General Hospital, Vienna (P.J.); Shire, Wayne, PA (M.U., S.V.); Shire, Lexington, MA (J.W., A.W.); and the Department of Infectious Diseases, University Hospital Essen, University Duisburg-Essen, Essen, Germany (O.W.).
Jaksch P; From the Hematology Department, University Hospitals Leuven, KU Leuven, Leuven (J.M.), and the Section of Hematology, Cliniques Universitaires Saint-Luc, Brussels (X.P.) - both in Belgium; the Hematology Department, Henri Mondor Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP) and University Paris-Est-Créteil, Créteil (C.C.), and AP-HP Hôpital Paul Brousse, Villejuif (F.S.) - all in France; the Medical University of Vienna, General Hospital, Vienna (P.J.); Shire, Wayne, PA (M.U., S.V.); Shire, Lexington, MA (J.W., A.W.); and the Department of Infectious Diseases, University Hospital Essen, University Duisburg-Essen, Essen, Germany (O.W.).
Poiré X; From the Hematology Department, University Hospitals Leuven, KU Leuven, Leuven (J.M.), and the Section of Hematology, Cliniques Universitaires Saint-Luc, Brussels (X.P.) - both in Belgium; the Hematology Department, Henri Mondor Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP) and University Paris-Est-Créteil, Créteil (C.C.), and AP-HP Hôpital Paul Brousse, Villejuif (F.S.) - all in France; the Medical University of Vienna, General Hospital, Vienna (P.J.); Shire, Wayne, PA (M.U., S.V.); Shire, Lexington, MA (J.W., A.W.); and the Department of Infectious Diseases, University Hospital Essen, University Duisburg-Essen, Essen, Germany (O.W.).
Uknis M; From the Hematology Department, University Hospitals Leuven, KU Leuven, Leuven (J.M.), and the Section of Hematology, Cliniques Universitaires Saint-Luc, Brussels (X.P.) - both in Belgium; the Hematology Department, Henri Mondor Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP) and University Paris-Est-Créteil, Créteil (C.C.), and AP-HP Hôpital Paul Brousse, Villejuif (F.S.) - all in France; the Medical University of Vienna, General Hospital, Vienna (P.J.); Shire, Wayne, PA (M.U., S.V.); Shire, Lexington, MA (J.W., A.W.); and the Department of Infectious Diseases, University Hospital Essen, University Duisburg-Essen, Essen, Germany (O.W.).
Wu J; From the Hematology Department, University Hospitals Leuven, KU Leuven, Leuven (J.M.), and the Section of Hematology, Cliniques Universitaires Saint-Luc, Brussels (X.P.) - both in Belgium; the Hematology Department, Henri Mondor Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP) and University Paris-Est-Créteil, Créteil (C.C.), and AP-HP Hôpital Paul Brousse, Villejuif (F.S.) - all in France; the Medical University of Vienna, General Hospital, Vienna (P.J.); Shire, Wayne, PA (M.U., S.V.); Shire, Lexington, MA (J.W., A.W.); and the Department of Infectious Diseases, University Hospital Essen, University Duisburg-Essen, Essen, Germany (O.W.).
Wijatyk A; From the Hematology Department, University Hospitals Leuven, KU Leuven, Leuven (J.M.), and the Section of Hematology, Cliniques Universitaires Saint-Luc, Brussels (X.P.) - both in Belgium; the Hematology Department, Henri Mondor Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP) and University Paris-Est-Créteil, Créteil (C.C.), and AP-HP Hôpital Paul Brousse, Villejuif (F.S.) - all in France; the Medical University of Vienna, General Hospital, Vienna (P.J.); Shire, Wayne, PA (M.U., S.V.); Shire, Lexington, MA (J.W., A.W.); and the Department of Infectious Diseases, University Hospital Essen, University Duisburg-Essen, Essen, Germany (O.W.).
Saliba F; From the Hematology Department, University Hospitals Leuven, KU Leuven, Leuven (J.M.), and the Section of Hematology, Cliniques Universitaires Saint-Luc, Brussels (X.P.) - both in Belgium; the Hematology Department, Henri Mondor Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP) and University Paris-Est-Créteil, Créteil (C.C.), and AP-HP Hôpital Paul Brousse, Villejuif (F.S.) - all in France; the Medical University of Vienna, General Hospital, Vienna (P.J.); Shire, Wayne, PA (M.U., S.V.); Shire, Lexington, MA (J.W., A.W.); and the Department of Infectious Diseases, University Hospital Essen, University Duisburg-Essen, Essen, Germany (O.W.).
Witzke O; From the Hematology Department, University Hospitals Leuven, KU Leuven, Leuven (J.M.), and the Section of Hematology, Cliniques Universitaires Saint-Luc, Brussels (X.P.) - both in Belgium; the Hematology Department, Henri Mondor Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP) and University Paris-Est-Créteil, Créteil (C.C.), and AP-HP Hôpital Paul Brousse, Villejuif (F.S.) - all in France; the Medical University of Vienna, General Hospital, Vienna (P.J.); Shire, Wayne, PA (M.U., S.V.); Shire, Lexington, MA (J.W., A.W.); and the Department of Infectious Diseases, University Hospital Essen, University Duisburg-Essen, Essen, Germany (O.W.).
Villano S; From the Hematology Department, University Hospitals Leuven, KU Leuven, Leuven (J.M.), and the Section of Hematology, Cliniques Universitaires Saint-Luc, Brussels (X.P.) - both in Belgium; the Hematology Department, Henri Mondor Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP) and University Paris-Est-Créteil, Créteil (C.C.), and AP-HP Hôpital Paul Brousse, Villejuif (F.S.) - all in France; the Medical University of Vienna, General Hospital, Vienna (P.J.); Shire, Wayne, PA (M.U., S.V.); Shire, Lexington, MA (J.W., A.W.); and the Department of Infectious Diseases, University Hospital Essen, University Duisburg-Essen, Essen, Germany (O.W.).
Pokaż więcej
Źródło :
The New England journal of medicine [N Engl J Med] 2019 Sep 19; Vol. 381 (12), pp. 1136-1147.
Typ publikacji :
Clinical Trial, Phase II; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Antiviral Agents/*therapeutic use
Benzimidazoles/*therapeutic use
Cytomegalovirus/*physiology
Cytomegalovirus Infections/*drug therapy
Ribonucleosides/*therapeutic use
Valganciclovir/*therapeutic use
Viremia/*drug therapy
Adult ; Aged ; Allografts ; Antiviral Agents/adverse effects ; Antiviral Agents/pharmacology ; Benzimidazoles/adverse effects ; Benzimidazoles/pharmacology ; Cytomegalovirus/drug effects ; Cytomegalovirus Infections/virology ; Dysgeusia/chemically induced ; Female ; Gastrointestinal Diseases/chemically induced ; Hematopoietic Stem Cell Transplantation/adverse effects ; Humans ; Intention to Treat Analysis ; Male ; Middle Aged ; Neutropenia/chemically induced ; Organ Transplantation/adverse effects ; Ribonucleosides/adverse effects ; Ribonucleosides/pharmacology ; Valganciclovir/adverse effects ; Valganciclovir/pharmacology ; Virus Activation/drug effects
Czasopismo naukowe
Tytuł :
Limited sampling strategy for the estimation of the area under the concentration-time curve for ganciclovir in Chinese adult renal allograft recipients.
Autorzy :
Rui WB; Center for Organ Transplantation, Rui-Jin Hospital, Shanghai Jiao-Tong University School of Medicine, 197 Ruijin Er Road, Shanghai, 200025, People's Republic of China.
An HM; Center for Organ Transplantation, Rui-Jin Hospital, Shanghai Jiao-Tong University School of Medicine, 197 Ruijin Er Road, Shanghai, 200025, People's Republic of China.
Shao K; Center for Organ Transplantation, Rui-Jin Hospital, Shanghai Jiao-Tong University School of Medicine, 197 Ruijin Er Road, Shanghai, 200025, People's Republic of China.
Zhai XH; Department of Pharmacy, Rui-Jin Hospital, Shanghai Jiao Tong University School of Medicine, 197 Ruijin Er Road, Shanghai, 200025, People's Republic of China.
Lu JQ; Department of Pharmacy, Rui-Jin Hospital, Shanghai Jiao Tong University School of Medicine, 197 Ruijin Er Road, Shanghai, 200025, People's Republic of China.
Hu SS; Department of Pharmacy, Rui-Jin Hospital, Shanghai Jiao Tong University School of Medicine, 197 Ruijin Er Road, Shanghai, 200025, People's Republic of China.
Chen B; Department of Pharmacy, Rui-Jin Hospital, Shanghai Jiao Tong University School of Medicine, 197 Ruijin Er Road, Shanghai, 200025, People's Republic of China. .
Zhou PJ; Center for Organ Transplantation, Rui-Jin Hospital, Shanghai Jiao-Tong University School of Medicine, 197 Ruijin Er Road, Shanghai, 200025, People's Republic of China. .
Pokaż więcej
Źródło :
European journal of clinical pharmacology [Eur J Clin Pharmacol] 2019 May; Vol. 75 (5), pp. 677-686. Date of Electronic Publication: 2019 Jan 14.
Typ publikacji :
Journal Article
MeSH Terms :
Kidney Transplantation*
Blood Specimen Collection/*methods
Ganciclovir/*blood
Valganciclovir/*blood
Adolescent ; Adult ; Antiviral Agents/blood ; Antiviral Agents/pharmacokinetics ; Antiviral Agents/therapeutic use ; Area Under Curve ; Asian Continental Ancestry Group ; Cytomegalovirus Infections/metabolism ; Cytomegalovirus Infections/prevention & control ; Drug Monitoring/methods ; Female ; Ganciclovir/pharmacokinetics ; Ganciclovir/therapeutic use ; Humans ; Immunosuppressive Agents/adverse effects ; Male ; Middle Aged ; Transplantation, Homologous ; Valganciclovir/pharmacokinetics ; Valganciclovir/therapeutic use
Czasopismo naukowe
Tytuł :
Prenatal Treatment of Congenital Cytomegalovirus With Valganciclovir: A Case Report.
Autorzy :
DeNoble AE; Department of Obstetrics and Gynecology, Duke University, Durham, North Carolina, USA.
Saccoccio FM; Pediatric Infectious Diseases, University of Florida Shands Children's Hospital, Gainesville, Florida, USA.
Permar SR; Department of Pediatrics, Children's Health and Discovery Institute, Duke University, Durham, North Carolina, USA.
Hughes BL; Department of Obstetrics and Gynecology, Duke University, Durham, North Carolina, USA.
Pokaż więcej
Źródło :
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2020 Dec 03; Vol. 71 (9), pp. 2506-2508.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Cytomegalovirus Infections*/drug therapy
Fetal Diseases*/drug therapy
Pregnancy Complications, Infectious*/drug therapy
Cytomegalovirus ; Female ; Humans ; Pregnancy ; Valganciclovir/therapeutic use
Czasopismo naukowe
Tytuł :
Prediction of poor neurological development in patients with symptomatic congenital cytomegalovirus diseases after oral valganciclovir treatment.
Autorzy :
Fukushima S; Department of Pediatrics, Kobe University Graduate School of Medicine, Kobe, Japan.
Morioka I; Department of Pediatrics, Kobe University Graduate School of Medicine, Kobe, Japan; Department of Pediatrics and Child Health, Nihon University School of Medicine, Tokyo, Japan. Electronic address: .
Ohyama S; Department of Pediatrics, Kobe University Graduate School of Medicine, Kobe, Japan.
Nishida K; Department of Pediatrics, Kobe University Graduate School of Medicine, Kobe, Japan.
Iwatani S; Department of Pediatrics, Kobe University Graduate School of Medicine, Kobe, Japan.
Fujioka K; Department of Pediatrics, Kobe University Graduate School of Medicine, Kobe, Japan.
Mandai T; Department of Pediatrics, Kobe University Graduate School of Medicine, Kobe, Japan.
Matsumoto H; Department of Clinical Laboratory, Kobe University Hospital, Kobe, Japan.
Nakamachi Y; Department of Clinical Laboratory, Kobe University Hospital, Kobe, Japan.
Deguchi M; Department of Obstetrics and Gynecology, Kobe University Graduate School of Medicine, Kobe, Japan.
Tanimura K; Department of Obstetrics and Gynecology, Kobe University Graduate School of Medicine, Kobe, Japan.
Iijima K; Department of Pediatrics, Kobe University Graduate School of Medicine, Kobe, Japan.
Yamada H; Department of Obstetrics and Gynecology, Kobe University Graduate School of Medicine, Kobe, Japan.
Pokaż więcej
Źródło :
Brain & development [Brain Dev] 2019 Oct; Vol. 41 (9), pp. 743-750. Date of Electronic Publication: 2019 May 07.
Typ publikacji :
Journal Article
MeSH Terms :
Antiviral Agents/*therapeutic use
Cytomegalovirus Infections/*congenital
Cytomegalovirus Infections/*drug therapy
Neurodevelopmental Disorders/*diagnosis
Valganciclovir/*therapeutic use
Administration, Oral ; Antiviral Agents/adverse effects ; Cytomegalovirus Infections/diagnosis ; Cytomegalovirus Infections/epidemiology ; Female ; Follow-Up Studies ; Humans ; Incidence ; Infant ; Male ; Neurodevelopmental Disorders/epidemiology ; Neurodevelopmental Disorders/etiology ; Prognosis ; Prospective Studies ; Valganciclovir/adverse effects
Czasopismo naukowe
Tytuł :
Extending cytomegalovirus prophylaxis in high-risk (D+/R-) lung transplant recipients from 6 to 9 months reduces cytomegalovirus disease: A retrospective study.
Autorzy :
Herrera S; Transplant Infectious Diseases, University Health Network/University of Toronto, Toronto, ON, Canada.
Khan B; Toronto Lung Transplant Program, University Health Network/University of Toronto, Toronto, ON, Canada.
Singer LG; Toronto Lung Transplant Program, University Health Network/University of Toronto, Toronto, ON, Canada.
Binnie M; Toronto Lung Transplant Program, University Health Network/University of Toronto, Toronto, ON, Canada.
Chaparro C; Toronto Lung Transplant Program, University Health Network/University of Toronto, Toronto, ON, Canada.
Chow CW; Toronto Lung Transplant Program, University Health Network/University of Toronto, Toronto, ON, Canada.
Martinu T; Toronto Lung Transplant Program, University Health Network/University of Toronto, Toronto, ON, Canada.
Tomlinson G; Department of Medicine, University Health Network / University of Toronto, Toronto, ON, Canada.
Keshavjee S; Toronto Lung Transplant Program, University Health Network/University of Toronto, Toronto, ON, Canada.
Husain S; Transplant Infectious Diseases, University Health Network/University of Toronto, Toronto, ON, Canada.
Tikkanen JM; Toronto Lung Transplant Program, University Health Network/University of Toronto, Toronto, ON, Canada.
Pokaż więcej
Źródło :
Transplant infectious disease : an official journal of the Transplantation Society [Transpl Infect Dis] 2020 Aug; Vol. 22 (4), pp. e13277. Date of Electronic Publication: 2020 Mar 27.
Typ publikacji :
Journal Article
MeSH Terms :
Drug Administration Schedule*
Transplant Recipients*
Antiviral Agents/*administration & dosage
Cytomegalovirus Infections/*prevention & control
Lung Transplantation/*adverse effects
Pre-Exposure Prophylaxis/*methods
Adult ; Aged ; Antiviral Agents/therapeutic use ; Female ; Ganciclovir/administration & dosage ; Ganciclovir/therapeutic use ; Graft Rejection/prevention & control ; Humans ; Male ; Middle Aged ; Retrospective Studies ; Risk Factors ; Time Factors ; Transplantation, Homologous ; Valganciclovir/administration & dosage ; Valganciclovir/therapeutic use
Czasopismo naukowe
Tytuł :
CMV as culprit or bystander: The debate continues.
Autorzy :
Yamada M; Department of Advanced Medicine for Viral Infections, National Center for Child Health and Development, Tokyo, Japan.
Pellett Madan R; Department of Pediatrics, NYU Grossman School of Medicine and Hassenfeld Children's Hospital at NYU Langone, New York, NY, USA.
Pokaż więcej
Źródło :
Pediatric transplantation [Pediatr Transplant] 2020 Dec; Vol. 24 (8), pp. e13865. Date of Electronic Publication: 2020 Oct 12.
Typ publikacji :
Letter; Comment
MeSH Terms :
Cytomegalovirus Infections*
Heart Transplantation*
Allografts ; Child ; Cytomegalovirus ; Humans ; Valganciclovir
Opinia redakcyjna
Tytuł :
Identification of antiviral compounds against equid herpesvirus-1 using real-time cell assay screening: Efficacy of decitabine and valganciclovir alone or in combination.
Autorzy :
Thieulent C; LABÉO Frank Duncombe, 14280, Saint-Contest, France; Normandie Univ, Unicaen, BIOTARGEN EA7450, 14280, Saint-Contest, France.
Hue ES; LABÉO Frank Duncombe, 14280, Saint-Contest, France; Normandie Univ, Unicaen, BIOTARGEN EA7450, 14280, Saint-Contest, France; Normandie Univ, UNICAEN, ImpedanCELL, 14280, Saint-Contest, France.
Sutton G; LABÉO Frank Duncombe, 14280, Saint-Contest, France; Normandie Univ, Unicaen, BIOTARGEN EA7450, 14280, Saint-Contest, France.
Fortier C; LABÉO Frank Duncombe, 14280, Saint-Contest, France; Normandie Univ, Unicaen, BIOTARGEN EA7450, 14280, Saint-Contest, France; Normandie Univ, UNICAEN, ImpedanCELL, 14280, Saint-Contest, France.
Dallemagne P; Normandie Univ, UNICAEN, CERMN, 14000, Caen, France.
Zientara S; Université Paris-Est, Laboratoire de Santé Animale, ANSES, INRAE, ENVA, UMR 1161 Virologie, 94700, Maisons-Alfort, France.
Munier-Lehmann H; Institut Pasteur, Unité de Chimie et Biocatalyse, CNRS UMR 3523, 75015, Paris, France.
Hans A; ANSES, Laboratoire de Santé Animale, Site de Normandie, PhEED Unit, 14430, Goustranville, France.
Paillot R; LABÉO Frank Duncombe, 14280, Saint-Contest, France; Normandie Univ, Unicaen, BIOTARGEN EA7450, 14280, Saint-Contest, France.
Vidalain PO; CIRI, Centre International de Recherche en Infectiologie, Univ Lyon, Inserm U1111, Université Claude Bernard Lyon 1, CNRS UMR5308, ENS de Lyon, F-69007, Lyon, France; Equipe Chimie et Biologie, Modélisation et Immunologie pour La Thérapie (CBMIT), Université Paris Descartes, CNRS UMR 8601, 75006, Paris, France.
Pronost S; LABÉO Frank Duncombe, 14280, Saint-Contest, France; Normandie Univ, Unicaen, BIOTARGEN EA7450, 14280, Saint-Contest, France; Normandie Univ, UNICAEN, ImpedanCELL, 14280, Saint-Contest, France. Electronic address: .
Pokaż więcej
Źródło :
Antiviral research [Antiviral Res] 2020 Nov; Vol. 183, pp. 104931. Date of Electronic Publication: 2020 Sep 11.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Antiviral Agents/*pharmacology
Decitabine/*pharmacology
Herpesviridae Infections/*veterinary
Herpesvirus 1, Equid/*drug effects
Valganciclovir/*pharmacology
Animals ; Cell Line ; Drug Combinations ; Drug Discovery/methods ; Drug Synergism ; Ganciclovir/pharmacology ; Herpesviridae Infections/drug therapy ; Herpesviridae Infections/virology ; High-Throughput Screening Assays/methods ; Horses ; Rabbits
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies